Skip to main content
Tisagenlecleucel vs conventional treatment improves survival in DLBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Tisagenlecleucel vs conventional treatment improves survival in DLBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Prognosis
0
0.85
B-Cell Lymphoma
0
1
Lymphoma
0
0.59
Refractory
0
0.65
Cancer
0
0.2
Chemotherapy
0
0.2
Drug and Treatment Safety
0
0.2
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Edit Tags